Efficiency of combined therapy with impaza and type 5 phosphodiesterase inhibitors in prophylactics of posttraumatic erectile dysfunction.
The use of combined pharmacotherapy with impaza and type 5 phosphodiesterase inhibitors helps to prevent and/or considerably reduce the risk of posttraumatic erectile dysfunction in men with traumas and strictures of the urethra. This therapy is indicated at early terms after trauma of the urethra for prophylactics of erectile dysfunction.
Ibishev
Kh S
KhS
Rostov State Medical University, Rostov-on-Don.
D000906:Antibodies / Q000627:therapeutic use*; D007172:Erectile Dysfunction / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D008297:Male; D010726:Phosphodiesterase Inhibitors / Q000627:therapeutic use*; D016896:Treatment Outcome; D014521:Urethra / Q000293:injuries*
D000906:Antibodies; C534505:IMPAZA; D010726:Phosphodiesterase Inhibitors